News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
875,065 Results
Type
Article (88290)
Company Profile (812)
Press Release (785942)
Multimedia
Podcasts (213)
Webinars (34)
Section
Business (233383)
Career Advice (4153)
Deals (39903)
Drug Delivery (160)
Drug Development (91512)
Employer Resources (206)
FDA (18465)
Job Trends (17448)
News (398232)
Policy (40003)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3030)
Academic (2)
Accelerated approval (42)
Adcomms (37)
Allergies (169)
Alliances (56984)
ALS (202)
Alzheimer's disease (1866)
Antibody-drug conjugate (ADC) (401)
Approvals (18673)
Artificial intelligence (714)
Autoimmune disease (233)
Automation (49)
Bankruptcy (406)
Best Places to Work (12634)
BIOSECURE Act (23)
Biosimilars (214)
Biotechnology (486)
Bladder cancer (185)
Brain cancer (71)
Breast cancer (721)
Cancer (5539)
Cardiovascular disease (490)
Career advice (3581)
Career pathing (45)
CAR-T (324)
CDC (69)
Celiac Disease (2)
Cell therapy (897)
Cervical cancer (42)
Clinical research (77675)
Collaboration (2022)
Company closure (6)
Compensation (1286)
Complete response letters (91)
COVID-19 (3010)
CRISPR (110)
C-suite (1014)
Cystic fibrosis (157)
Data (7015)
Decentralized trials (2)
Denatured (79)
Depression (173)
Diabetes (580)
Diagnostics (7381)
Digital health (55)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (348)
Drug pricing (233)
Drug shortages (36)
Duchenne muscular dystrophy (283)
Earnings (101067)
Editorial (70)
Employer branding (25)
Employer resources (174)
Events (136251)
Executive appointments (1095)
FDA (21939)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (14)
Frontotemporal dementia (29)
Funding (1692)
Gene editing (237)
Generative AI (75)
Gene therapy (744)
GLP-1 (1190)
Government (5494)
Grass and pollen (8)
Guidances (395)
Healthcare (20996)
HIV (78)
Huntington's disease (57)
IgA nephropathy (92)
Immunology and inflammation (316)
Immuno-oncology (87)
Indications (151)
Infectious disease (3349)
Inflammatory bowel disease (221)
Inflation Reduction Act (17)
Influenza (135)
Intellectual property (277)
Interviews (817)
IPO (17973)
IRA (61)
Job creations (5203)
Job search strategy (2869)
JPM (73)
Kidney cancer (20)
Labor market (103)
Layoffs (666)
Leadership (44)
Legal (10169)
Liver cancer (102)
Longevity (27)
Lung cancer (740)
Lymphoma (408)
Machine learning (54)
Management (66)
Manufacturing (979)
MASH (190)
Medical device (15126)
Medtech (15204)
Mergers & acquisitions (23078)
Metabolic disorders (1556)
mRNA (211)
Multiple sclerosis (181)
NASH (24)
Neurodegenerative disease (418)
Neuropsychiatric disorders (112)
Neuroscience (3354)
Neurotech (1)
NextGen: Class of 2026 (7712)
Non-profit (5127)
Now hiring (73)
Obesity (761)
Opinion (352)
Ovarian cancer (181)
Pain (242)
Pancreatic cancer (260)
Parkinson's disease (352)
Partnered (39)
Patents (566)
Patient recruitment (589)
Peanut (65)
People (67289)
Pharmaceutical (139)
Pharmacy benefit managers (34)
Phase 1 (23997)
Phase 2 (33711)
Phase 3 (25385)
Pipeline (6746)
Policy (369)
Postmarket research (3554)
Preclinical (10777)
Press Release (72)
Prostate cancer (284)
Psychedelics (61)
Radiopharmaceuticals (323)
Rare diseases (1077)
Real estate (7445)
Recruiting (81)
Regulatory (29511)
Reports (72)
Research institute (2752)
Resumes & cover letters (653)
Rett syndrome (33)
RNA editing (21)
RSV (93)
Schizophrenia (169)
Series A (286)
Series B (209)
Service/supplier (30)
Sickle cell disease (111)
Special edition (29)
Spinal muscular atrophy (182)
Sponsored (51)
Startups (4344)
State (2)
Stomach cancer (21)
Supply chain (125)
Tariffs (101)
The Weekly (131)
Vaccines (1206)
Venture capital (107)
Weight loss (519)
Women's health (112)
Worklife (23)
Date
Today (31)
Last 7 days (618)
Last 30 days (3018)
Last 365 days (32733)
2026 (7393)
2025 (33227)
2024 (38127)
2023 (42567)
2022 (53929)
2021 (58724)
2020 (57666)
2019 (51337)
2018 (39122)
2017 (37190)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1291)
Alabama (96)
Alaska (7)
Arizona (364)
Arkansas (15)
Asia (51787)
Australia (9098)
California (12552)
Canada (3554)
China (1283)
Colorado (534)
Connecticut (551)
Delaware (377)
Europe (119226)
Florida (1867)
Georgia (406)
Hawaii (4)
Idaho (68)
Illinois (1055)
India (83)
Indiana (588)
Iowa (24)
Japan (485)
Kansas (136)
Kentucky (49)
Louisiana (38)
Maine (85)
Maryland (1557)
Massachusetts (9199)
Michigan (383)
Minnesota (706)
Mississippi (7)
Missouri (151)
Montana (37)
Nebraska (30)
Nevada (139)
New Hampshire (89)
New Jersey (3366)
New Mexico (33)
New York (3308)
North Carolina (1717)
North Dakota (10)
Northern California (6096)
Ohio (386)
Oklahoma (23)
Oregon (54)
Pennsylvania (2501)
Puerto Rico (26)
Rhode Island (53)
South America (1668)
South Carolina (74)
South Dakota (1)
Southern California (4877)
Tennessee (201)
Texas (1994)
United States (45128)
Utah (379)
Vermont (1)
Virginia (318)
Washington D.C. (88)
Washington State (1036)
West Virginia (4)
Wisconsin (141)
Wyoming (2)
There are 875,065 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Insights
Validated Mechanisms, Strong Data Beat Hype in Longevity Investing
Longevity is a long-standing buzzword in life sciences, but it now has staying power. The smart trajectory is to stop chasing aging as an abstract target and concentrate on specific mechanisms that can clearly advance specific, age-related diseases, according to two investors in a discussion with
BioSpace.
March 23, 2026
·
3 min read
·
Jennifer C. Smith-Parker
Press Releases
Harbour BioMed Reports the Online Publication of Phase I Results for HBM9378 (SKB378/WIN378), a TSLP-Targeting Antibody
March 23, 2026
·
6 min read
Press Releases
Innovent Announces First Participant Dosed of IBI128 (Tigulixostat, XOI) in Phase 3 Clinical Study
March 23, 2026
·
7 min read
Press Releases
HUTCHMED Initiates Phase III Trial of HMPL-760 in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma in China
March 23, 2026
·
5 min read
Press Releases
Apogee Therapeutics to Host Conference Call to Report Part A 52-Week Data from the Phase 2 APEX Trial of Zumilokibart (APG777) in Patients with Moderate-to-Severe Atopic Dermatitis on March 23, 2026
March 23, 2026
·
1 min read
Press Releases
IDEAYA Biosciences Upcoming Investor Relations Events and Updated Darovasertib Topline Results Guidance from Phase 2/3 OptimUM-02 Trial
March 23, 2026
·
3 min read
Press Releases
Prothena Partners Present Data Supporting Next Generation Treatments for Parkinson’s and Alzheimer’s Disease at AD/PD™ 2026
March 23, 2026
·
7 min read
Press Releases
IBA Launches myQAMatriXXAiR to Advance Patient‑Specific QA in Particle Therapy
March 23, 2026
·
3 min read
Press Releases
Dizal Announces Positive Topline Phase 3 Results from WU-KONG28 Study: Evaluating Oral, Once-Daily ZEGFROVY® (Sunvozertinib) vs. Platinum-Containing Chemo Doublet in First-Line Non-Small Cell Lung Cancer (NSCLC) with EGFR Exon 20 Insertion Mutation (exon20ins)
March 23, 2026
·
6 min read
Press Releases
Omeros Announces Upcoming Presentation at EBMT 2026 Highlighting Advances in TA-TMA Treatment
March 23, 2026
·
2 min read
1 of 87,507
Next
